Ackman’s Pershing Square Holdings Loses 15.9% on Valeant
Bill Ackman, founder and chief executive officer of Pershing Square Capital Management LP.
Photographer: Andrew Harrer/BloombergThis article is for subscribers only.
Pershing Square Holdings, the publicly traded security of Bill Ackman’s activist hedge fund, extended losses over the past week amid attacks on Valeant Pharmaceuticals International Inc., bringing its decline this year to 15.9 percent.
The latest returns, reported weekly, are as of Oct. 27. The year-to-date decline as of Oct. 20 was 11.2 percent, according to Pershing Square Holdings’ website.